Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Endocrinology

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1210/EN.2003-0128PMID 12746286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population.

  2002cited by this paper
• Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells.

  2002cited by this paper
• Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases

  2002cited by this paper
• Cardiac fibrosis in mice lacking brain natriuretic peptide.

  2000cited by this paper
• Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct.

  2000cited by this paper
• Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes.

  2000cited by this paper
• Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts.

  1999cited by this paper
• Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1beta and tumor necrosis factor-alpha.

  1998cited by this paper
• Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts

  1998cited by this paper
• Production and secretion of adrenomedullin in cultured rat cardiac myocytes and nonmyocytes: stimulation by interleukin-1beta and tumor necrosis factor-alpha.

  1998cited by this paper
• Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A.

  1997cited by this paper
• Production of C-type natriuretic peptide in human aortic endothelial cells induced by activation of protein kinase C.

  1996cited by this paper
• Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.

  1995cited by this paper
• Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.

  1995cited by this paper
• Gene expression of natriuretic peptide receptors in myocardial cells.

  1995cited by this paper
• Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B.

  1994cited by this paper
• Natriuretic peptide system in human heart failure.

  1993cited by this paper
• Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue.

  1993cited by this paper
• Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs.

  1993cited by this paper
• Evidence for C-type natriuretic peptide production in the rat kidney.

  1993cited by this paper
• Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

  1993cited by this paper
• Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.

  1992cited by this paper
• Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene.

  1992cited by this paper
• Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system".

  1992cited by this paper
• Isolation and identification of C-type natriuretic peptide in human monocytic cell line, THP-1.

  1992cited by this paper
• C-type natriuretic peptide (CNP) in rats and humans.

  1991cited by this paper
• Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors.

  1991cited by this paper
• Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP).

  1991cited by this paper
• C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

  1990cited by this paper

• CNP inhibits T3 - induced hypertrophic growth in H9c2 cells: Impact of HDAC inhibitor.

  2025cites this paper
• Research Progress on the Role and Mechanism in the Change of Cardiac Structure and Function of Cardiac Fibrosis in the Elderly.

  2025cites this paper
• Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves’ Orbitopathy: A Proteomic Study

  2025cites this paper
• Heart failure is the most negative consequence of CABG surgery (importance of exercise rehabilitation approach)

  2025cites this paper
• Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm

  2025cites this paper
• Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF

  2024cites this paper
• Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia

  2024cites this paper
• Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators

  2024cites this paper
• Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension

  2024cites this paper
• Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies

  2024cites this paper
• NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways

  2023cites this paper
• Bioinspired Oligo-Urethane Nanoparticles for Delivering Exogenous C-Type Natriuretic Peptide: Synthetic Biomaterial Nanocarrier Complexes and Their Interactions with Cardiac Myofibroblasts.

  2023cites this paper
• C-type natriuretic peptide (CNP) in the paraventricular nucleus-mediated renal sympatho-inhibition

  2023influential citation
• The Predictive Value of A, B, and C-Type Natriuretic Peptides in People at Risk of Heart Disease: Protocol for a Longitudinal Observational Study

  2023cites this paper
• Vascular endothelial cell-specific overexpression of CNP did not improve liver fibrosis in HFFCD-induced NASH, but did improve renal lesions.

  2023cites this paper
• CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System

  2022influential citation
• Elevated N-terminal pro C-type natriuretic peptide is associated with mortality in patients undergoing transcatheter aortic valve replacement

  2022cites this paper
• Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart

  2022cites this paper
• Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide

  2022cites this paper
• Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)

  2021cites this paper
• Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction

  2021cites this paper
• Autocrine Signaling in Cardiac Remodeling: A Rich Source of Therapeutic Targets

  2021cites this paper
• Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19

  2021cites this paper
• Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure.

  2021cites this paper
• Cardiac morphological and functional changes induced by C-type natriuretic peptide are different in normotensive and spontaneously hypertensive rats

  2020cites this paper
• Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction.

  2020cites this paper
• C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness

  2020cites this paper
• Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation.

  2020cites this paper
• C-Type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature

  2019influential citation
• C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts.

  2019cites this paper
• Atrial and brain natriuretic peptides: Hormones secreted from the heart.

  2019cites this paper
• C-type natriuretic peptide co-ordinates cardiac structure and function

  2019cites this paper
• C-type natriuretic peptide regulates sperm capacitation by the cGMP/PKG signalling pathway via Ca2+ influx and tyrosine phosphorylation.

  2019cites this paper
• Natriuretic peptides as therapeutic agents

  2019cites this paper
• Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use.

  2019cites this paper
• C-type natriuretic peptide prevents angiotensin II-induced atrial connexin 40 and 43 dysregulation by activating AMP-activated kinase signaling

  2019cites this paper
• Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics

  2019cites this paper
• Cardiovascular Pleiotropic Effects of Natriuretic Peptides

  2019cites this paper
• C-Type Natriuretic Peptide Dampens Fibroblast Growth Factor-23 Expression Through MAPK Signaling Pathway in Human Mesangial Cells

  2018cites this paper
• Evolving Role of Natriuretic Peptides from Diagnostic Tool to Therapeutic Modality.

  2018cites this paper
• A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

  2018cites this paper
• Nppa and Nppb act redundantly during zebrafish cardiac development to confine AVC marker expression and reduce cardiac jelly volume

  2018cites this paper
• Using Peptidomics to Identify Extracellular Matrix-Derived Peptides as Novel Therapeutics for Cardiac Disease

  2018cites this paper
• Role of C-type natriuretic peptide in cardiac structure and function

  2018cites this paper
• Inhibition of Renal Fibrosis and Glomerular Injury by Sacubitril/Valsartan, a Combination Angiotensin Receptor Blocker and Neprilysin Inhibitor, in a Salt-Sensitive Hypertensive Model Using Angiotensin 1 Receptor Knockout Mice: The Contribution of Non-Angiotensin Blocking Effects to Renal Protection

  2018influential citation
• Natriuretic Peptide Receptor-C Protects Against Angiotensin II-Mediated Sinoatrial Node Disease in Mice

  2018cites this paper
• Cellular Mechanisms of Valvular Thickening in Early and Intermediate Calcific Aortic Valve Disease

  2018cites this paper
• Natriuretic Peptide Receptor B modulates the proliferation of the cardiac cells expressing the Stem Cell Antigen-1

  2017cites this paper
• Cardiac Natriuretic Peptides

  2017cites this paper
• The role of natriuretic peptides in regulation of cardiovascular system

  2017cites this paper
• Cyclic GMP/Protein Kinase Localized Signaling and Disease Implications

  2017cites this paper
• Compartmentation of Natriuretic Peptide Signalling in Cardiac Myocytes: Effects on Cardiac Contractility and Hypertrophy

  2017cites this paper
• Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice

  2017cites this paper
• Association of NPR3 polymorphism with risk of essential hypertension in a Chinese population

  2017cites this paper
• Microdomains in the Cardiovascular System

  2017cites this paper
• Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure

  2017cites this paper
• MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS

  2016cites this paper
• Targeting multidrug resistance proteins and C-type natriuretic peptide to optimise cyclic GMP signalling in cardiovascular disease

  2016cites this paper
• C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice

  2016cites this paper
• Elevated C-type natriuretic peptide elicits exercise preconditioning-induced cardioprotection against myocardial injury probably via the up-regulation of NPR-B

  2016cites this paper
• Estudios Moleculares y Celulares del Sistema de Endotelinas en Cáncer Colorectal

  2016cites this paper
• Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice

  2016cites this paper
• Molecular Physiology of Membrane Guanylyl Cyclase Receptors.

  2016cites this paper
• Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

  2016cites this paper
• Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes.

  2016influential citation
• ardiorenal fibrosis and dysfunction in aging : Imbalance in mediators nd regulators of collagen

  2016cites this paper
• Cenderitide: a multivalent designer-peptide-agonist of particulate guanylyl cyclase receptors with considerable therapeutic potential in cardiorenal disease states.

  2016cites this paper
• Angiotensin receptor neprilysin inhibition in heart failure: mechanistic action and clinical impact.

  2015cites this paper
• Circulating C-Type Natriuretic Peptide and Its Relationship to Cardiovascular Disease in the General Population

  2015cites this paper
• New medical therapies for heart failure

  2015cites this paper
• Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events

  2015influential citation
• Associations Between Genetic Variants of the Natriuretic Peptide System and Blood Pressure Response to Dietary Sodium Intervention: The GenSalt Study.

  2015cites this paper
• Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.

  2015cites this paper
• Ularitide: a natriuretic peptide candidate for the treatment of acutely decompensated heart failure.

  2015cites this paper
• Review Article Angiotensin Receptor Neprilysin Inhibition in Heart Failure: Mechanistic Action and Clinical Impact

  2015cites this paper
• Natriuretic Peptides: Critical Regulators of Cardiac Fibroblasts and the Extracellular Matrix in the Heart

  2015influential citation
• Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C

  2015cites this paper
• Rationale and Therapeutic Opportunities for Natriuretic Peptide System Augmentation in Heart Failure

  2015cites this paper
• C-type natriuretic peptide prevents angiotensin II-induced cardiac remodelling and dysfunction

  2015cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2015cites this paper
• The heart as an endocrine organ

  2014cites this paper
• In vitro and in vivo studies of controlled release of novel peptide from in situ polymer precipitation delivery system

  2014cites this paper
• Regulatory RNAs and paracrine networks in the heart.

  2014cites this paper
• Atrial Natriuretic Peptide Affects Cardiac Remodeling, Function, Heart Failure, and Survival in a Mouse Model of Dilated Cardiomyopathy

  2014cites this paper
• Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1

  2014cites this paper
• Natriuretic peptides in animal models of cardiovascular disease

  2014cites this paper
• Rate of increase in serum lactate level risk-stratifies infants after surgery for congenital heart disease.

  2014cites this paper
• Natriuretic peptides in cardiometabolic regulation and disease

  2014cites this paper
• Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis

  2014cites this paper
• Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.

  2013cites this paper
• C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity.

  2013cites this paper
• Novel Vasodilators in Heart Failure

  2013cites this paper
• C-type natriuretic peptide: a new cardiac mediator.

  2013cites this paper
• NATRIURETIC PEPTIDES MODULATE HEART RATE, ELECTRICAL CONDUCTION AND ARRHYTHMOGENSIS IN VIVO

  2013cites this paper
• Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis.

  2013cites this paper
• Chapter 192 – Natriuretic Peptides

  2013cites this paper
• In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide

  2013cites this paper
• Survival in a Mouse Model of Dilated Cardiomyopathy Atrial Natriuretic Peptide Affects Cardiac Remodeling

  2013cites this paper
• CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart

  2012influential citation
• Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling

  2012cites this paper